Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Transplantation
|
September 26, 2007
Outcomes after orthotopic liver transplantation in 15 HIV-infected patients
Ian Schreibman, Jeffrey J Gaynor, Dushyantha Jayaweera, et al.
BMC Gastroenterology
|
October 16, 2015
Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database
Nancy D Lin, Heather Norman, Arie Regev, et al.
Journal of Translational Autoimmunity
|
July 1, 2021
Baricitinib and primary biliary cholangitis
Stuart C Gordon, Sheri Trudeau, Arie Regev, et al.
Postgraduate Medicine
|
July 26, 2008
Answers to the most common questions about the hepatic safety profile of duloxetine
Madelaine M Wohlreich, Nayan Acharya, Indiana Strombom, et al.
Drug Safety
|
March 28, 2008
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder
Mark E Bangs, Ling Jin, Shuyu Zhang, et al.
Drug Safety
|
August 5, 2025
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative
Melissa Palmer, Daniel Seekins, Mark Avigan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 6, 2007
Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list
Melissa K Osborn, Steven H Han, Arie Regev, et al.
Journal of Addictive Diseases
|
August 7, 2008
Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami
Marianna K Baum, Dushyantha T Jayaweera, Rui Duan, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2024
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study
Amita Datta-Mannan, Arie Regev, David E Coutant, et al.
The American Journal of Gastroenterology
|
October 19, 2002
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Arie Regev, Mariana Berho, Lennox J Jeffers, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Transplantation
|
September 26, 2007
Outcomes after orthotopic liver transplantation in 15 HIV-infected patients
Ian Schreibman, Jeffrey J Gaynor, Dushyantha Jayaweera, et al.
BMC Gastroenterology
|
October 16, 2015
Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database
Nancy D Lin, Heather Norman, Arie Regev, et al.
Journal of Translational Autoimmunity
|
July 1, 2021
Baricitinib and primary biliary cholangitis
Stuart C Gordon, Sheri Trudeau, Arie Regev, et al.
Postgraduate Medicine
|
July 26, 2008
Answers to the most common questions about the hepatic safety profile of duloxetine
Madelaine M Wohlreich, Nayan Acharya, Indiana Strombom, et al.
Drug Safety
|
March 28, 2008
Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder
Mark E Bangs, Ling Jin, Shuyu Zhang, et al.
Drug Safety
|
August 5, 2025
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative
Melissa Palmer, Daniel Seekins, Mark Avigan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 6, 2007
Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list
Melissa K Osborn, Steven H Han, Arie Regev, et al.
Journal of Addictive Diseases
|
August 7, 2008
Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami
Marianna K Baum, Dushyantha T Jayaweera, Rui Duan, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2024
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754): A Phase I Randomized Placebo-Controlled Study
Amita Datta-Mannan, Arie Regev, David E Coutant, et al.
The American Journal of Gastroenterology
|
October 19, 2002
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection
Arie Regev, Mariana Berho, Lennox J Jeffers, et al.
Page
of 7